Paylocity Corporation
PCTY
$111.33
+6.51%
Paylocity Holding Corporation is a leading provider of cloud-based human capital management (HCM) and payroll software solutions, operating in the competitive Software - Application industry. The company has established itself as a significant player in the mid-market segment, serving nearly 42,000 customers primarily in the US by unifying HR, finance, and IT operations on a single platform. The current investor narrative is dominated by a significant stock price correction and concerns over growth deceleration, as evidenced by the sharp year-over-year decline in share price, which has prompted a debate about its competitive positioning and future margin trajectory in a potentially slowing economic environment. Recent financial results and the subsequent market reaction are central to the discussion around its ability to maintain its growth premium.…
PCTY
Paylocity Corporation
$111.33
Investment Opinion: Should I buy PCTY Today?
Rating & Thesis: The stock is a Hold. The core thesis is that Paylocity is a fundamentally sound, cash-generative business caught in a painful transition from high-growth to moderate-growth, with the current price reflecting this uncertainty but not offering a sufficient margin of safety for a Buy rating. Analyst consensus remains cautiously optimistic, but the lack of a clear average target price amid the steep decline underscores the uncertainty.
Supporting Evidence: The forward P/E of 11.6x is compelling if the $9.57 EPS estimate is achieved, representing a significant discount to its historical multiples. Revenue, while decelerating, is still growing at 10.4% YoY, and the company maintains strong profitability with a 12.1% net margin and 67.8% gross margin. Robust free cash flow generation of $444M TTM and a pristine balance sheet (D/E 0.18) provide downside protection and flexibility for share buybacks. However, the elevated trailing P/E of 44.4x and PEG of 4.1 signal the market is still pricing in a growth recovery that has not yet materialized.
Risks & Conditions: The two biggest risks are 1) growth decelerating further below 10%, invalidating the forward earnings estimates, and 2) continued multiple compression if it is re-rated as a value stock. This Hold would upgrade to a Buy if the forward P/E compresses further towards 10x while growth stabilizes above 10%, or if quarterly results show a re-acceleration in revenue growth. It would downgrade to a Sell if revenue growth falls below 5% or if forward EPS estimates are meaningfully cut. The stock is fairly valued relative to its near-term prospects but carries significant execution risk.
Sign up to view all
PCTY 12-Month Price Forecast
The investment case for PCTY is balanced between a compelling forward valuation and clear fundamental deterioration in growth. The forward P/E of 11.6x prices in a significant earnings recovery and suggests limited downside if executed, but the recent 10.4% revenue growth casts doubt on that execution. The stock's technical picture is bleak, but the strong cash flow and low debt provide fundamental support. The stance is neutral, as the stock appears to be in a 'show me' phase. We would upgrade to bullish on evidence of growth stabilization or re-acceleration in the next two quarters. We would downgrade to bearish if revenue growth falls below 8% or forward EPS estimates are cut.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Paylocity Corporation's 12-month outlook, with a consensus price target around $144.73 and implied upside of +30.0% versus the current price.
Average Target
$144.73
14 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
14
covering this stock
Price Range
$89 - $145
Analyst target range
Paylocity is covered by 14 analysts, indicating substantial institutional research coverage. The consensus sentiment leans bullish, as evidenced by recent ratings from firms like Keybanc (Overweight), Stifel (Buy), and Citigroup (Buy), though there is a neutral stance from UBS and Barclays (Equal Weight). The average target price is not provided in the data, so the implied upside/downside cannot be calculated; however, the distribution of recent actions suggests analysts are largely maintaining positive ratings despite the stock's steep decline. The target price range is also not available in the provided data, preventing a detailed analysis of the bull and bear cases. The presence of multiple recent ratings from February 2026, all reiterating existing positions, indicates analysts are digesting the latest earnings and may be awaiting clearer signs of a fundamental turnaround before making significant changes to their targets. The lack of downgrades amidst a -43% yearly decline suggests analysts see value at current levels or believe the long-term thesis remains intact.
Bulls vs Bears: PCTY Investment Factors
The bear case currently holds stronger evidence, anchored by the severe and ongoing growth deceleration from 28% to 10% YoY, which directly challenges the stock's historical growth premium. The bullish argument rests on a compelling forward valuation (11.6x P/E) and strong cash generation, but this requires a successful earnings recovery that is not yet evident in recent quarterly results. The single most important tension in the investment debate is whether the current forward P/E of 11.6x accurately prices in the company's transition to a slower-growth, cash-generative enterprise, or if further multiple compression is warranted if growth stalls below 10%. The resolution of this growth trajectory will determine if the stock is a deep value opportunity or a value trap.
Bullish
- Strong Forward Earnings Growth: The forward P/E of 11.6x is significantly lower than the trailing P/E of 44.4x, implying the market expects a substantial earnings recovery. This is supported by the forward EPS estimate of $9.57, suggesting strong projected profitability and a potential valuation re-rating if achieved.
- Robust Free Cash Flow Generation: The company generated $444.27M in TTM free cash flow, providing ample internal capital for growth and shareholder returns. This strong cash generation, coupled with a low debt-to-equity ratio of 0.18, indicates a healthy, self-funding business model with low financial risk.
- Deeply Oversold Technical Condition: The stock is trading at $100.89, only 9% above its 52-week low of $92.99, after a -43.3% one-year decline. This severe underperformance and proximity to support suggest most negative news may be priced in, creating a potential entry point for value-oriented investors.
- Solid Profitability and Margins: The company maintains healthy profitability with a 12.1% net margin and a 67.8% gross margin in its latest quarter. A robust operating margin of 17.0% demonstrates the business model's ability to generate operating leverage despite growth deceleration.
Bearish
- Severe Growth Deceleration: Revenue growth has slowed dramatically to 10.4% YoY in Q2 FY2026, down from 28% YoY in Q3 FY2025. This deceleration in the core subscription business (recurring fees of $370M) raises concerns about market saturation, competitive pressures, or a maturing growth profile.
- Elevated Trailing Valuation Multiples: A trailing P/E of 44.4x is high for a company growing revenue at 10%. The PEG ratio of 4.1 suggests the stock is expensive relative to its growth rate, indicating the valuation still embeds expectations for a growth re-acceleration that may not materialize.
- Persistent Downtrend and Weak Momentum: The stock is in a sustained downtrend, down -10.7% over the past month and -7.9% over three months, severely underperforming the S&P 500's +11.7% gain. This persistent selling pressure and a -52.6% max drawdown indicate significant negative momentum and lack of buyer conviction.
- Volatile and Declining Profitability: Quarterly net income has been volatile, dropping from $91.5M in Q3 FY2025 to $50.2M in the latest quarter. This 45% sequential decline suggests potential margin compression or increased investment spend, which could pressure earnings growth and challenge the forward P/E thesis.
PCTY Technical Analysis
The stock is in a pronounced and sustained downtrend, with a 1-year price change of -43.26%, significantly underperforming the broader market. Currently trading at $100.89, the price sits near the lower end of its 52-week range ($92.99 to $197.78), positioning it at approximately 9% above the 52-week low, which suggests the stock is deeply oversold and may present a potential value opportunity, though it remains a 'falling knife' until a clear reversal pattern emerges. Recent momentum shows continued weakness, with the stock down -10.73% over the past month and -7.95% over the past three months, indicating the selling pressure has persisted and accelerated relative to the longer-term downtrend. This divergence from the S&P 500, which is up 11.69% over three months, highlights severe relative weakness, with a 1-month relative strength of -9.11% underscoring its poor performance versus the market. Key technical support is firmly established at the 52-week low of $92.99, while resistance lies at the 52-week high of $197.78; a decisive break below support could signal a continuation of the downtrend towards new lows, while reclaiming levels above $115-$120 is needed to suggest a potential bottoming process. The stock's beta of 0.505 indicates it has been about 50% less volatile than the S&P 500 over the measured period, which is unusual for a growth software name and may reflect a loss of speculative interest, though the recent price action and a max drawdown of -52.58% demonstrate significant absolute risk.
Beta
0.51
0.51x market volatility
Max Drawdown
-51.8%
Largest decline past year
52-Week Range
$93-$198
Price range past year
Annual Return
-38.9%
Cumulative gain past year
| Period | PCTY Return | S&P 500 |
|---|---|---|
| 1m | -9.1% | -1.7% |
| 3m | +4.9% | +13.7% |
| 6m | -23.6% | +9.2% |
| 1y | -38.9% | +20.7% |
| ytd | -23.6% | +9.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PCTY Fundamental Analysis
Revenue growth remains positive but has shown signs of deceleration; the most recent quarterly revenue (Q2 FY2026) was $416.13 million, representing a year-over-year growth of 10.39%, which is a slowdown from the stronger growth rates seen in prior quarters (e.g., 28% YoY in Q3 FY2025). The revenue mix is overwhelmingly driven by Recurring Fees, which accounted for $370.08 million of the total, while Implementation Services contributed $19.62 million, indicating the core subscription model is intact but growth momentum is moderating. The company is profitable, with net income of $50.20 million in the latest quarter and a net margin of 12.06%, supported by a healthy gross margin of 67.80%. Profitability has been somewhat volatile on a quarterly basis, with net income down from $91.48 million in Q3 FY2025, suggesting potential margin compression or increased investment; the operating margin for the latest quarter was 16.97%, showing the business model can generate solid operating leverage. The balance sheet is robust with a low debt-to-equity ratio of 0.18, indicating minimal financial leverage and low solvency risk. The company generated strong free cash flow of $444.27 million on a trailing twelve-month basis, providing ample internal funding for growth and shareholder returns, as evidenced by significant stock repurchase activity; the current ratio of 1.14 points to sufficient short-term liquidity to meet obligations.
Quarterly Revenue
$416134000.0B
2025-12
Revenue YoY Growth
+0.10%
YoY Comparison
Gross Margin
+0.67%
Latest Quarter
Free Cash Flow
$444266000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PCTY Overvalued?
Given the company's positive net income, the primary valuation metric selected is the Price-to-Earnings (P/E) ratio. The trailing P/E ratio is elevated at 44.41x, while the forward P/E is significantly lower at 11.60x, indicating the market expects a substantial recovery in earnings over the next twelve months, likely driven by the forward EPS estimate of $9.57. Compared to sector averages (data not provided in the input), a trailing P/E of 44.4x would typically command a premium, justified only by high growth expectations; however, the forward multiple of 11.6x suggests the market has already priced in a normalization or significant earnings growth. Historically, the stock's own valuation has compressed dramatically from much higher levels; for instance, its P/E ratio was above 170x in late 2022 and 60x in late 2024. The current trailing P/E of 44.4x, while high in absolute terms, is near the lower end of its own multi-year historical range, reflecting the severe derating the stock has undergone and potentially pricing in the recent growth deceleration and market pessimism.
PE
44.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 28x~330x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
23.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is the sharp deceleration in revenue growth to 10.4% YoY, which pressures the elevated trailing P/E of 44.4x and raises questions about the sustainability of the forward earnings estimate of $9.57. Profitability volatility is a concern, with net income falling 45% sequentially from $91.5M to $50.2M, indicating potential margin pressure from increased competition or investment needs. While the balance sheet is strong with a debt-to-equity of 0.18 and robust free cash flow of $444M, the company's valuation remains heavily dependent on re-accelerating growth to justify its historical premium.
Market & Competitive Risks: The stock faces significant valuation compression risk, as its trailing P/E of 44.4x and PEG of 4.1 are high for its current growth rate, leaving it vulnerable to further de-rating if growth does not re-accelerate. Competitive disruption in the crowded HCM/payroll software market could further pressure pricing and market share. The stock's beta of 0.5 suggests it has become de-correlated from growth peers and may not participate in a broader market rally, while its severe -65.5% one-year relative strength versus the S&P 500 indicates it is being shunned by growth investors.
Worst-Case Scenario: The worst-case scenario involves a continuation of the growth deceleration below 10%, coupled with margin compression, leading to a miss on the forward EPS estimate of $9.57. This would invalidate the forward P/E thesis, triggering multiple contraction towards value stock levels (e.g., a P/E of 15-20x) and analyst downgrades. The stock could re-test and break its 52-week low of $92.99, approaching the lows seen during the 2022 bear market. A realistic downside from the current price of $100.89 is approximately -20% to -30%, targeting a range of $70-$80, representing a further de-rating on failed growth expectations.
FAQ
The key risks are, in order of severity: 1) Growth Deceleration Risk: Revenue growth slowed to 10.4% YoY from 28%; further slowing could crush the forward earnings thesis. 2) Valuation Compression Risk: The high trailing P/E of 44.4x leaves the stock vulnerable to further de-rating if growth doesn't re-accelerate. 3) Competitive/Market Risk: The HCM/payroll software market is crowded; pricing pressure could hurt margins. 4) Execution Risk: Quarterly net income has been volatile, dropping 45% sequentially, raising concerns about the company's ability to hit the $9.57 forward EPS estimate. The stock's -43% one-year decline and high short interest of 3.64 reflect these pervasive concerns.
The 12-month outlook for PCTY is defined by three scenarios. The base case (55% probability) sees the stock trading between $110 and $135, assuming revenue growth stabilizes around 10% and the company meets the $9.57 forward EPS estimate. The bull case (25% probability) targets $150-$180, requiring a re-acceleration of growth above 15% and a successful valuation re-rating. The bear case (20% probability) projects a decline to $80-$95 if growth slows further and earnings disappoint. The base case is most likely, as it aligns with current analyst expectations and the company's recent performance, but it is heavily dependent on the assumption that forward earnings estimates are accurate.
PCTY's valuation presents a paradox. On a trailing basis, it looks expensive with a P/E of 44.4x and a PEG ratio of 4.1, which is difficult to justify given 10% revenue growth—this suggests overvaluation. However, the forward P/E of 11.6x, based on expected EPS of $9.57, appears deeply undervalued for a profitable software company. The stock is trading at a significant discount to its own historical multiples, which have compressed from over 170x. The market is currently valuing PCTY as if its high-growth phase is over, pricing in a transition to a moderate-growth, cash-generative business. The verdict is that it is fairly valued to slightly undervalued on forward earnings, but this hinges entirely on the company delivering those future profits.
PCTY presents a high-risk, potentially high-reward opportunity at current levels. The forward P/E of 11.6x is compelling if the company hits its $9.57 EPS estimate, implying significant upside if growth stabilizes. However, with revenue growth decelerating sharply to 10.4% and the stock in a persistent downtrend, it carries substantial execution risk. It could be a good buy for value investors with a long-term horizon who believe the growth story is not broken, but it is not suitable for growth-focused investors or those with low risk tolerance. The 20% probability bear case suggests a potential downside to $80, which must be weighed against the base case target of $110-$135.
PCTY is unsuitable for short-term trading due to its high volatility, negative momentum (-10.7% past month), and lack of near-term positive catalysts. It is better suited for long-term investors with a minimum 2-3 year horizon who can wait for the company to either prove its forward earnings power or for a potential growth turnaround. The low beta of 0.5 is deceptive given its -52.6% max drawdown; this reflects a stock that has been sold off, not one with low volatility. The absence of a dividend means total return is dependent solely on price appreciation. Given the current 'show me' story and transition phase, patience is required, making it a long-term, thesis-driven holding.